Farhana Nakhooda

In this episode of Owning the Future of Healthcare, a Health Catalyst podcast, Farhana Nakhooda, Senior Vice President of Health Catalyst Asia Pacific (APAC), discusses the current state of data and analytics in APAC, the reason behind the growing interest in data-driven healthcare, and how different markets (both developing and developed) are overcoming barriers to […]

Along with the rest of the globe, 2021 healthcare trends across Asia-Pacific (APAC) countries will center on COVID-19 recovery and resuming the healthcare improvement journey. In the APAC region, however, a mix of developed and developing countries poses unique challenges, as healthcare access and basic infrastructure vary widely between urban and rural populations and economic levels. To shepherd healthcare out of the pandemic and enhance delivery overall in 2021, APAC nations will focus on increasing investment in digital health (including virtual care, machine learning, and EMR adoption), achieving universal health coverage, shifting more towards value, and improving payer-provider relationships.

Along with the rest of the globe, 2021 healthcare trends across Asia-Pacific (APAC) countries will center on COVID-19 recovery and resuming the healthcare improvement journey. In the APAC region, however, a mix of developed and developing countries poses unique challenges, as healthcare access and basic infrastructure vary widely between urban and rural populations and economic levels. To shepherd healthcare out of the pandemic and enhance delivery overall in 2021, APAC nations will focus on increasing investment in digital health (including virtual care, machine learning, and EMR adoption), achieving universal health coverage, shifting more towards value, and improving payer-provider relationships.

If governments and healthcare providers thought it was difficult to plan for COVID-19 testing and contact tracing, the public vaccination process will be another monumental challenge. The Advisory Committee on Immunization Practices, an independent panel that reports to the Centers for Disease Control and Prevention (CDC), recommended that frontline healthcare workers should be first in […]

In addition to driving COVID-19 understanding within the United States, a national disease registry is informing research beyond U.S. borders. Clinicians with the Singapore Ministry of Healthcare Office for Healthcare Transformation (MOHT) have used Health Catalyst Touchstone^®利用COVID-19数据开发机器学习工具，帮助预测COVID-19死亡的可能性。有了这个利用深度聚合的电子病历数据的国家数据集，卫生部访问了它所需的研究级数据，以构建一个预测COVID-19死亡风险的机器学习算法。登记信息的预测模型足够准确，足以经得起发表文献的比较，并有望为疫苗研究提供信息，并最终在人群中分配疫苗。

In addition to driving COVID-19 understanding within the United States, a national disease registry is informing research beyond U.S. borders. Clinicians with the Singapore Ministry of Healthcare Office for Healthcare Transformation (MOHT) have used Health Catalyst Touchstone® COVID-19 data to develop a machine learning tool that helps predict the likelihood of COVID-19 mortality.
有了这个利用深度聚合的电子病历数据的国家数据集，卫生部访问了它所需的研究级数据，以构建一个预测COVID-19死亡风险的机器学习算法。
登记信息的预测模型足够准确，足以经得起发表文献的比较，并有望为疫苗研究提供信息，并最终在人群中分配疫苗。